Скачать или смотреть Creation of a Robust Infrastructure Including Molecular, Neurobehavior & Biomarker Testing

Kyle Fink, Ph.D.; David Segal, Ph.D.; Jill Silverman, Ph.D. discuss how an Angelman syndrome pre-clinical infrastructure at UC Davis was created for testing new therapeutic compounds.



Disclaimer: The information contained in these slides is provided for informational purposes only and should not be construed as medical, legal, financial, or any other type of professional advice. The views and opinions expressed in this presentation and on the following slides are solely those of the presenter and not necessarily those of FAST. FAST does not guarantee the accuracy or reliability of the information provided herein.

Under no circumstances, including negligence, shall FAST or its officers, directors, employees, partners, or licensors be liable for any direct, indirect, incidental, special, punitive, or consequential damages that may result from the access of, or use, or inability to use content from this presentation.

Unauthorized modification, reproduction, translation, or distribution of any part of these slides is strictly prohibited.